BridgeMD
Compares treatment options for Interstitial Lung Disease (ILD)
Official title Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease
ClinicalTrials.gov ID: NCT07500818
What this study is testing
- What it's testing
- Interstitial lung disease (ILD) often requires histopathological confirmation when high-resolution computed tomography (HRCT) findings are inconclusive. Transbronchial lung cryobiopsy has emerged as a less invasive alternative to surgical lung biopsy, but diagnostic yield remains variable and dependent on biopsy location and procedural precision.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Age ≥18 years
- Clinical suspicion of interstitial lung disease requiring histological confirmation
- Non-diagnostic HRCT pattern (e.g. probable UIP or indeterminate pattern)
- Candidate for transbronchial lung cryobiopsy
- Ability to provide informed consent
You likely can't join if
- Definite UIP pattern on HRCT
- Severe pulmonary hypertension
- Severe hypoxemia contraindicating bronchoscopy
- Coagulopathy or contraindication to biopsy
- Pregnancy
- Inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Lucerne, Canton of Lucerne, Switzerland
- Zurich, Canton of Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lucerne, Canton of Lucerne, Switzerland; Zurich, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.